advertisement
Editors Selection IGR 7-3
List of Editor's Selection comments by
Louis Cantor
Chair and Professor of Ophthalmology, Jay C. and Lucile L. Kahn Professor of Glaucoma Research and Education, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis Indiana, USA
Medical Treatment: Properties of generic latanoprost solutions (18-3, July 2017) on:
71551 The physical properties of generic latanoprost ophthalmic solutions are not identical
Kolko M; Koch Jensen P
Acta Ophthalmologica 2017; 95: 370-373
Medical Treatment: Are generic formulations up to quality standards? (14-1, November 2012) on:
48653 A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry
Kahook MY; Fechtner RD; Katz LJ et al.
Current Eye Research 2012; 37: 101-108
Medical Treatment: Alternate daily use of travoprost (13-4, April 2012) on:
47783 A short-term randomized clinical trial of daily versus alternate day use of travoprost 0.004% in the treatment of ocular hypertension
Khairy HA; Said-Ahmed K
Journal of Glaucoma 2011;
Medical Therapy: Bimatoprost once daily vs every other day (13-3, December 2011) on:
46843 Comparison of intraocular pressure-lowering effect of every night versus every other night dosing of bimatoprost 0.03%
Shazly TA; Latina MA
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 369-371
Surgical Treatment: Phacotrab versus phacotrabeculotomy/deep sclerectomy (10-3, December 2008) on:
21762 A prospective trial of phaco-trabeculotomy combined with deep sclerectomy versus phaco-trabeculectomy
Lüke C; Dietlein TS; Lüke M et al.
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 1163-1168
Medical treatment: Treatment variations (7-3, March 2006) on:
13067 Persistence and adherence with topical glaucoma therapy
Nordstrom BL; Friedman DS; Mozaffari E et al.
American Journal of Ophthalmology 2005; 140: 598-606
